speb/financial-data huggingface dataset:
GMED balance_sheet (annual, 2024-12-31) — Tangible Book Value: 1949829000.00
GMED income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -14212107.00
GMED income_statement (annual, 2024-12-31) — Tax Provision: 17738000.00
GMED income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.15
GMED balance_sheet (annual, 2024-12-31) — Taxes Receivable: 20633000.00
GMED balance_sheet (annual, 2024-12-31) — Total Assets: 5251750000.00
GMED balance_sheet (annual, 2024-12-31) — Total Capitalization: 4177333000.00
GMED balance_sheet (annual, 2024-12-31) — Total Debt: 537188000.00
GMED balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 4177333000.00
GMED income_statement (annual, 2024-12-31) — Total Expenses: 2299968000.00
GMED balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 1074417000.00
GMED balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 3074490000.00
GMED balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 218504000.00
GMED income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 165991000.00
GMED income_statement (annual, 2024-12-31) — Total Other Finance Cost: 4189000.00
GMED balance_sheet (annual, 2024-12-31) — Total Tax Payable: 44813000.00
GMED income_statement (annual, 2024-12-31) — Total Unusual Items: -96681000.00
GMED income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -96681000.00
GMED balance_sheet (annual, 2024-12-31) — Work In Process: 45775000.00
GMED balance_sheet (annual, 2024-12-31) — Working Capital: 1321347000.00
GMED income_statement (quarterly, 2025-03-31) — +Operating Expense: 304663000.00
GMED income_statement (quarterly, 2025-03-31) — +Total Revenue: 598121000.00
GMED balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 73144000.00
GMED balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 535090000.00
GMED balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -571728000.00
GMED balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 3053927000.00
GMED balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -8488000.00
GMED income_statement (quarterly, 2025-03-31) — Amortization: 28802000.00
GMED cash_flow (quarterly, 2025-03-31) — Amortization Cash Flow: 28802000.00
GMED cash_flow (quarterly, 2025-03-31) — Amortization Of Intangibles: 28802000.00
GMED income_statement (quarterly, 2025-03-31) — Amortization Of Intangibles Income Statement: 28802000.00
GMED cash_flow (quarterly, 2025-03-31) — Amortization Of Securities: -421000.00
GMED income_statement (quarterly, 2025-03-31) — Basic Average Shares: 136757000.00
GMED income_statement (quarterly, 2025-03-31) — Basic EPS: 0.55
GMED cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 784438000.00
GMED balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 101957000.00
GMED cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -36103000.00
GMED balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 92313000.00
GMED balance_sheet (quarterly, 2025-03-31) — Capital Stock: 135000.00
GMED balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 461266000.00
GMED balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 461266000.00
GMED cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -635396000.00
GMED cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 131385000.00
GMED cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 177300000.00
GMED cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -899000.00
GMED cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -28658000.00
GMED cash_flow (quarterly, 2025-03-31) — Change In Inventory: -7587000.00
GMED cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: 19608000.00
GMED cash_flow (quarterly, 2025-03-31) — Change In Payable: -899000.00
GMED cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -29557000.00
GMED cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 4534000.00
GMED cash_flow (quarterly, 2025-03-31) — Change In Receivables: 22603000.00
GMED cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 9601000.00
GMED cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 22603000.00
GMED cash_flow (quarterly, 2025-03-31) — Changes In Cash: -326711000.00
GMED balance_sheet (quarterly, 2025-03-31) — Common Stock: 135000.00
GMED balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 4088068000.00
GMED cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -190451000.00
GMED income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 195397000.00
GMED balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 70391000.00
GMED balance_sheet (quarterly, 2025-03-31) — Current Assets: 1710114000.00
GMED balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 10622000.00
GMED balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 10622000.00
GMED balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 17172000.00
GMED balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 17172000.00
GMED balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 384701000.00
GMED cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: 509000.00
GMED cash_flow (quarterly, 2025-03-31) — Deferred Tax: 509000.00
GMED cash_flow (quarterly, 2025-03-31) — Depreciation: 37272000.00
GMED cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 65653000.00
GMED income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 28802000.00
GMED cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 65653000.00
GMED income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 28802000.00
GMED income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 139774000.00
GMED income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.54
GMED income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 75462000.00
GMED income_statement (quarterly, 2025-03-31) — EBIT: 98061000.00
GMED income_statement (quarterly, 2025-03-31) — EBITDA: 163714000.00
GMED cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 3539000.00
GMED cash_flow (quarterly, 2025-03-31) — End Cash Position: 461266000.00
GMED cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -635396000.00
GMED balance_sheet (quarterly, 2025-03-31) — Finished Goods: 497031000.00
GMED cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 141197000.00
GMED income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: 4270000.00
GMED balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -2167000.00
GMED balance_sheet (quarterly, 2025-03-31) — Goodwill: 1432964000.00
GMED balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 2204652000.00
GMED balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 543578000.00
GMED balance_sheet (quarterly, 2025-03-31) — Gross PPE: 1176591000.00
GMED income_statement (quarterly, 2025-03-31) — Gross Profit: 402724000.00
GMED cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 7199000.00
GMED balance_sheet (quarterly, 2025-03-31) — Income Tax Payable: 12739000.00
GMED balance_sheet (quarterly, 2025-03-31) — Inventory: 663603000.00
GMED balance_sheet (quarterly, 2025-03-31) — Invested Capital: 4088068000.00
GMED cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 131385000.00
GMED balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 0.00
GMED balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 0.00
GMED balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 9741000.00
GMED balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 81691000.00
GMED balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 81691000.00
GMED cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -449985000.00
GMED cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: -5000000.00
GMED cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -190451000.00
GMED cash_flow (quarterly, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: -3772000.00
GMED income_statement (quarterly, 2025-03-31) — Net Income: 75462000.00
GMED income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 75462000.00
GMED income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 75462000.00
GMED income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 75462000.00
GMED income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 75462000.00
GMED cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 75462000.00
GMED income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 75462000.00
GMED cash_flow (quarterly, 2025-03-31) — Net Intangibles Purchase And Sale: -5000000.00
GMED income_statement (quarterly, 2025-03-31) — Net Interest Income: 1681000.00
GMED cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 172488000.00
GMED cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -449985000.00
GMED cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -449985000.00
GMED income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 1681000.00
GMED cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -6183000.00
GMED balance_sheet (quarterly, 2025-03-31) — Net PPE: 604863000.00
GMED cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -36103000.00
GMED balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 1883416000.00
GMED balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 116663000.00
GMED balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 46605000.00
GMED balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 116663000.00
GMED balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 46605000.00
GMED income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 160501000.00
GMED income_statement (quarterly, 2025-03-31) — Normalized Income: 73122936.00
GMED cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 177300000.00
GMED cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -1159000.00
GMED income_statement (quarterly, 2025-03-31) — Operating Income: 98061000.00
GMED income_statement (quarterly, 2025-03-31) — Operating Revenue: 598121000.00
GMED balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 135356442.00
GMED balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 47131000.00
GMED balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 33458000.00
GMED balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -2167000.00
GMED income_statement (quarterly, 2025-03-31) — Other Income Expense: 3926000.00
GMED balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 771688000.00
GMED cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 4862000.00
GMED balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 74856000.00
GMED balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 110083000.00
GMED income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 713000.00
GMED balance_sheet (quarterly, 2025-03-31) — Other Properties: 1064893000.00
GMED balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 0.00
GMED balance_sheet (quarterly, 2025-03-31) — Payables: 122589000.00
GMED balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 192980000.00
GMED balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 130469000.00
GMED income_statement (quarterly, 2025-03-31) — Pretax Income: 103668000.00
GMED cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 11223000.00
GMED balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
GMED cash_flow (quarterly, 2025-03-31) — Provisionand Write Offof Assets: 9166000.00
GMED cash_flow (quarterly, 2025-03-31) — Purchase Of Business: -5000000.00
GMED cash_flow (quarterly, 2025-03-31) — Purchase Of Intangibles: -5000000.00
GMED cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -1750000.00
GMED cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -36103000.00
GMED balance_sheet (quarterly, 2025-03-31) — Raw Materials: 118574000.00
GMED balance_sheet (quarterly, 2025-03-31) — Receivables: 538114000.00
GMED income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 158546000.00
GMED income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 65653000.00
GMED cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -449985000.00
GMED cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -190451000.00
GMED income_statement (quarterly, 2025-03-31) — Research And Development: 33062000.00
GMED income_statement (quarterly, 2025-03-31) — Restructuring And Mergern Acquisition: 1057000.00
GMED balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 1036173000.00
GMED cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 174238000.00
GMED income_statement (quarterly, 2025-03-31) — Selling General And Administration: 242799000.00
GMED balance_sheet (quarterly, 2025-03-31) — Share Issued: 135356442.00
GMED income_statement (quarterly, 2025-03-31) — Special Income Charges: -1057000.00
GMED cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 13206000.00
GMED balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 4088068000.00
GMED balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 1883416000.00
GMED income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 873936.00
GMED income_statement (quarterly, 2025-03-31) — Tax Provision: 28206000.00
GMED income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.27
GMED balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 3024000.00
GMED balance_sheet (quarterly, 2025-03-31) — Total Assets: 4711148000.00
GMED balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 4088068000.00
GMED balance_sheet (quarterly, 2025-03-31) — Total Debt: 92313000.00
GMED balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 4088068000.00
GMED income_statement (quarterly, 2025-03-31) — Total Expenses: 500060000.00
GMED balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 623080000.00
GMED balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 3001034000.00
GMED balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 238379000.00
GMED income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 97004000.00
GMED income_statement (quarterly, 2025-03-31) — Total Other Finance Cost: -1681000.00
GMED balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 49445000.00
GMED income_statement (quarterly, 2025-03-31) — Total Unusual Items: 3213000.00
GMED income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 3213000.00
GMED balance_sheet (quarterly, 2025-03-31) — Work In Process: 47998000.00
GMED balance_sheet (quarterly, 2025-03-31) — Working Capital: 1325413000.00
GMED income_statement (quarterly, 2025-06-30) — +Operating Expense: 373765000.00
GMED income_statement (quarterly, 2025-06-30) — +Total Revenue: 745342000.00
GMED balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 87099000.00
GMED balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 611565000.00
GMED balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -601753000.00
GMED balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 3071652000.00
GMED balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -26607000.00
GMED income_statement (quarterly, 2025-06-30) — Amortization: 30189000.00
GMED cash_flow (quarterly, 2025-06-30) — Amortization Cash Flow: 30189000.00
GMED cash_flow (quarterly, 2025-06-30) — Amortization Of Intangibles: 30189000.00
GMED income_statement (quarterly, 2025-06-30) — Amortization Of Intangibles Income Statement: 30189000.00
GMED cash_flow (quarterly, 2025-06-30) — Amortization Of Securities: 0.00
GMED income_statement (quarterly, 2025-06-30) — Basic Average Shares: 135205000.00
GMED income_statement (quarterly, 2025-06-30) — Basic EPS: 1.50
GMED cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 461266000.00
GMED balance_sheet (quarterly, 2025-06-30) — Buildings And Improvements: 119793000.00
GMED cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -51562000.00
GMED balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 121104000.00
GMED balance_sheet (quarterly, 2025-06-30) — Capital Stock: 135000.00
GMED balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 229446000.00
GMED balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 229446000.00
GMED cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -24937000.00
GMED cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -299108000.00
GMED cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 77865000.00
GMED cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -3186000.00
GMED cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 14817000.00
GMED cash_flow (quarterly, 2025-06-30) — Change In Inventory: -4135000.00
GMED cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -58234000.00
GMED cash_flow (quarterly, 2025-06-30) — Change In Payable: -3186000.00
GMED cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 11631000.00
GMED cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -3682000.00
GMED cash_flow (quarterly, 2025-06-30) — Change In Receivables: -2208000.00
GMED cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -56628000.00
GMED cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -2208000.00
GMED cash_flow (quarterly, 2025-06-30) — Changes In Cash: -246180000.00
GMED balance_sheet (quarterly, 2025-06-30) — Common Stock: 135000.00
GMED balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 4295683000.00
GMED cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -25000000.00
GMED income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 248765000.00
GMED balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 87150000.00
GMED balance_sheet (quarterly, 2025-06-30) — Current Assets: 1729902000.00
GMED balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 13179000.00
GMED balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 13179000.00
GMED balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 24020000.00
GMED balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 24020000.00
GMED balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 424664000.00
GMED cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: -41745000.00
GMED cash_flow (quarterly, 2025-06-30) — Deferred Tax: -41745000.00
GMED cash_flow (quarterly, 2025-06-30) — Depreciation: 40441000.00
GMED cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 71052000.00
GMED income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 30189000.00
GMED cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 71052000.00
GMED income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 30189000.00
GMED income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 136499000.00
GMED income_statement (quarterly, 2025-06-30) — Diluted EPS: 1.49
GMED income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 202846000.00
GMED income_statement (quarterly, 2025-06-30) — EBIT: 122812000.00
GMED income_statement (quarterly, 2025-06-30) — EBITDA: 193864000.00
GMED cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 14360000.00
GMED cash_flow (quarterly, 2025-06-30) — End Cash Position: 229446000.00
GMED cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -24937000.00
GMED balance_sheet (quarterly, 2025-06-30) — Finished Goods: 558372000.00
GMED cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 26303000.00
GMED income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 38000.00
GMED balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 10239000.00
GMED balance_sheet (quarterly, 2025-06-30) — Goodwill: 1434983000.00
GMED balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 2231355000.00
GMED balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 638172000.00
GMED balance_sheet (quarterly, 2025-06-30) — Gross PPE: 1250845000.00
GMED income_statement (quarterly, 2025-06-30) — Gross Profit: 496577000.00
GMED cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 86027000.00
GMED balance_sheet (quarterly, 2025-06-30) — Income Tax Payable: 0.00
GMED balance_sheet (quarterly, 2025-06-30) — Inventory: 772131000.00
GMED balance_sheet (quarterly, 2025-06-30) — Invested Capital: 4295683000.00
GMED cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -299108000.00
GMED balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 0.00
GMED balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 0.00
GMED balance_sheet (quarterly, 2025-06-30) — Land And Improvements: 9765000.00
GMED balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 107925000.00
GMED balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 107925000.00
GMED cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: -247546000.00
GMED cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -25000000.00
GMED cash_flow (quarterly, 2025-06-30) — Net Foreign Currency Exchange Gain Loss: -7570000.00
GMED income_statement (quarterly, 2025-06-30) — Net Income: 202846000.00
GMED income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 202846000.00
GMED income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 202846000.00
GMED income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 202846000.00
GMED income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 202846000.00
GMED cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 202846000.00
GMED income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 202846000.00
GMED cash_flow (quarterly, 2025-06-30) — Net Intangibles Purchase And Sale: 0.00
GMED income_statement (quarterly, 2025-06-30) — Net Interest Income: 693000.00
GMED cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 0.00
GMED cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 0.00
GMED income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 693000.00
GMED cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -4634000.00
GMED balance_sheet (quarterly, 2025-06-30) — Net PPE: 649092000.00
GMED cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -46562000.00
GMED balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 2064328000.00
GMED balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 275897000.00
GMED balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 24402000.00
GMED balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 275897000.00
GMED balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 24402000.00
GMED income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 129968000.00
GMED income_statement (quarterly, 2025-06-30) — Normalized Income: 152368160.00
GMED cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 77865000.00
GMED cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -4052000.00
GMED income_statement (quarterly, 2025-06-30) — Operating Income: 122812000.00
GMED income_statement (quarterly, 2025-06-30) — Operating Revenue: 745342000.00
GMED balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 135050305.00
GMED balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 68202000.00
GMED balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 18619000.00
GMED balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 10239000.00
GMED income_statement (quarterly, 2025-06-30) — Other Income Expense: 64668000.00
GMED balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 796372000.00
GMED cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: -113125000.00
GMED balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 74843000.00
GMED balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 108415000.00
GMED income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 772000.00
GMED balance_sheet (quarterly, 2025-06-30) — Other Properties: 1121287000.00
GMED balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 0.00
GMED balance_sheet (quarterly, 2025-06-30) — Payables: 125959000.00
GMED balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 213109000.00
GMED balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 155737000.00
GMED income_statement (quarterly, 2025-06-30) — Pretax Income: 188173000.00
GMED cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 4697000.00
GMED balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
GMED cash_flow (quarterly, 2025-06-30) — Provisionand Write Offof Assets: 6321000.00
GMED cash_flow (quarterly, 2025-06-30) — Purchase Of Business: -247546000.00
GMED cash_flow (quarterly, 2025-06-30) — Purchase Of Intangibles: 0.00
GMED cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: 0.00
GMED cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -46562000.00
GMED balance_sheet (quarterly, 2025-06-30) — Raw Materials: 153311000.00
GMED balance_sheet (quarterly, 2025-06-30) — Receivables: 660123000.00
GMED income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 207902000.00
GMED income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 71052000.00
GMED cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: 0.00
GMED cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -25000000.00
GMED income_statement (quarterly, 2025-06-30) — Research And Development: 39954000.00
GMED income_statement (quarterly, 2025-06-30) — Restructuring And Mergern Acquisition: -63858000.00
GMED balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 1213657000.00
GMED cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 0.00
GMED income_statement (quarterly, 2025-06-30) — Selling General And Administration: 303622000.00
GMED balance_sheet (quarterly, 2025-06-30) — Share Issued: 135050305.00
GMED income_statement (quarterly, 2025-06-30) — Special Income Charges: 63858000.00
GMED cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 13617000.00
GMED balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 4295683000.00
GMED balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 2064328000.00
GMED income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 13418160.00
GMED income_statement (quarterly, 2025-06-30) — Tax Provision: -14673000.00
GMED income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.21
GMED balance_sheet (quarterly, 2025-06-30) — Taxes Receivable: 48558000.00
GMED balance_sheet (quarterly, 2025-06-30) — Total Assets: 4961089000.00
GMED balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 4295683000.00
GMED balance_sheet (quarterly, 2025-06-30) — Total Debt: 121104000.00
GMED balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 4295683000.00
GMED income_statement (quarterly, 2025-06-30) — Total Expenses: 622530000.00
GMED balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 665406000.00
GMED balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 3231187000.00
GMED balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 240742000.00
GMED income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 76109000.00
GMED income_statement (quarterly, 2025-06-30) — Total Other Finance Cost: -693000.00
GMED balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 38860000.00
GMED income_statement (quarterly, 2025-06-30) — Total Unusual Items: 63896000.00
GMED income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 63896000.00
GMED balance_sheet (quarterly, 2025-06-30) — Work In Process: 60448000.00
GMED balance_sheet (quarterly, 2025-06-30) — Working Capital: 1305238000.00
GMED income_statement (quarterly, 2025-09-30) — +Operating Expense: 381507000.00
GMED income_statement (quarterly, 2025-09-30) — +Total Revenue: 769048000.00
GMED balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 87227000.00
GMED balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 619116000.00
GMED balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -646664000.00
GMED balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 3095279000.00
GMED balance_sheet (quarterly, 2025-09-30) — Allowance For Doubtful Accounts Receivable: -27406000.00
GMED income_statement (quarterly, 2025-09-30) — Amortization: 29843000.00
GMED cash_flow (quarterly, 2025-09-30) — Amortization Cash Flow: 29843000.00
GMED cash_flow (quarterly, 2025-09-30) — Amortization Of Intangibles: 29843000.00
GMED income_statement (quarterly, 2025-09-30) — Amortization Of Intangibles Income Statement: 29843000.00
GMED cash_flow (quarterly, 2025-09-30) — Amortization Of Securities: -53000.00
GMED income_statement (quarterly, 2025-09-30) — Basic Average Shares: 134502000.00
GMED income_statement (quarterly, 2025-09-30) — Basic EPS: 0.88
GMED cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 229446000.00
GMED balance_sheet (quarterly, 2025-09-30) — Buildings And Improvements: 125364000.00
GMED cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -40483000.00
GMED balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 119343000.00
GMED balance_sheet (quarterly, 2025-09-30) — Capital Stock: 134000.00
GMED balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 371769000.00
GMED balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 390523000.00
GMED cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -32042000.00
GMED cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -75842000.00
GMED cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 249695000.00
GMED cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 3431000.00
GMED cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 39283000.00
GMED cash_flow (quarterly, 2025-09-30) — Change In Inventory: -5698000.00
GMED cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -19310000.00
GMED cash_flow (quarterly, 2025-09-30) — Change In Payable: 3431000.00
GMED cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 42714000.00
GMED cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -7541000.00
GMED cash_flow (quarterly, 2025-09-30) — Change In Receivables: -8424000.00
GMED cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 1741000.00
GMED cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -8424000.00
GMED cash_flow (quarterly, 2025-09-30) — Changes In Cash: 141811000.00
GMED balance_sheet (quarterly, 2025-09-30) — Common Stock: 134000.00
GMED balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 4398825000.00
GMED cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -40000000.00
GMED income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 252533000.00
GMED balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 120829000.00
GMED balance_sheet (quarterly, 2025-09-30) — Current Assets: 1924361000.00
GMED balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 14355000.00
GMED balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 14355000.00
GMED balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 18267000.00
GMED balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 18267000.00
GMED balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 465958000.00
GMED cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 41761000.00
GMED cash_flow (quarterly, 2025-09-30) — Deferred Tax: 41761000.00
GMED cash_flow (quarterly, 2025-09-30) — Depreciation: 41284000.00
GMED cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 71126000.00
GMED income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 29843000.00
GMED cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 71126000.00
GMED income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 29843000.00
GMED income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 135394000.00
GMED income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.88
GMED income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 118966000.00
GMED income_statement (quarterly, 2025-09-30) — EBIT: 135008000.00
GMED income_statement (quarterly, 2025-09-30) — EBITDA: 206134000.00
GMED cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 512000.00
GMED cash_flow (quarterly, 2025-09-30) — End Cash Position: 371769000.00
GMED cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -32042000.00
GMED balance_sheet (quarterly, 2025-09-30) — Finished Goods: 555735000.00
GMED cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 209212000.00
GMED income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: -161000.00
GMED balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 10927000.00
GMED balance_sheet (quarterly, 2025-09-30) — Goodwill: 1434291000.00
GMED balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 2208193000.00
GMED balance_sheet (quarterly, 2025-09-30) — Gross Accounts Receivable: 646522000.00
GMED balance_sheet (quarterly, 2025-09-30) — Gross PPE: 1283866000.00
GMED income_statement (quarterly, 2025-09-30) — Gross Profit: 516515000.00
GMED cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 1870000.00
GMED balance_sheet (quarterly, 2025-09-30) — Income Tax Payable: 1285000.00
GMED balance_sheet (quarterly, 2025-09-30) — Inventory: 771538000.00
GMED balance_sheet (quarterly, 2025-09-30) — Invested Capital: 4398825000.00
GMED cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -75842000.00
GMED balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 16684000.00
GMED balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 16684000.00
GMED balance_sheet (quarterly, 2025-09-30) — Land And Improvements: 9767000.00
GMED balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 104988000.00
GMED balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 104988000.00
GMED cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: 0.00
GMED cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -40000000.00
GMED cash_flow (quarterly, 2025-09-30) — Net Foreign Currency Exchange Gain Loss: -3279000.00
GMED income_statement (quarterly, 2025-09-30) — Net Income: 118966000.00
GMED income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 118966000.00
GMED income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 118966000.00
GMED income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 118966000.00
GMED income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 118966000.00
GMED cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 118966000.00
GMED income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 118966000.00
GMED cash_flow (quarterly, 2025-09-30) — Net Intangibles Purchase And Sale: -4666000.00
GMED income_statement (quarterly, 2025-09-30) — Net Interest Income: 1455000.00
GMED cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -35359000.00
GMED cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 0.00
GMED income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 1455000.00
GMED cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -3121000.00
GMED balance_sheet (quarterly, 2025-09-30) — Net PPE: 637202000.00
GMED cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -35817000.00
GMED cash_flow (quarterly, 2025-09-30) — Net Short Term Debt Issuance: 0.00
GMED balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 2190632000.00
GMED balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 232362000.00
GMED balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 22538000.00
GMED balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 232362000.00
GMED balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 22538000.00
GMED income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 200140000.00
GMED income_statement (quarterly, 2025-09-30) — Normalized Income: 114014956.00
GMED cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 249695000.00
GMED cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -972000.00
GMED income_statement (quarterly, 2025-09-30) — Operating Income: 135008000.00
GMED income_statement (quarterly, 2025-09-30) — Operating Revenue: 769048000.00
GMED balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 134605452.00
GMED balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 74177000.00
GMED balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 18900000.00
GMED balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 10927000.00
GMED income_statement (quarterly, 2025-09-30) — Other Income Expense: 7531000.00
GMED balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 773902000.00
GMED cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: -224000.00
GMED balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 76838000.00
GMED balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 103331000.00
GMED income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 1537000.00
GMED balance_sheet (quarterly, 2025-09-30) — Other Properties: 1148735000.00
GMED balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 18754000.00
GMED balance_sheet (quarterly, 2025-09-30) — Payables: 136551000.00
GMED balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 257380000.00
GMED balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 157056000.00
GMED income_statement (quarterly, 2025-09-30) — Pretax Income: 143994000.00
GMED cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 11079000.00
GMED balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
GMED cash_flow (quarterly, 2025-09-30) — Provisionand Write Offof Assets: 5812000.00
GMED cash_flow (quarterly, 2025-09-30) — Purchase Of Business: 0.00
GMED cash_flow (quarterly, 2025-09-30) — Purchase Of Intangibles: -4666000.00
GMED cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -35359000.00
GMED cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -35817000.00
GMED balance_sheet (quarterly, 2025-09-30) — Raw Materials: 152125000.00
GMED balance_sheet (quarterly, 2025-09-30) — Receivables: 688123000.00
GMED income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 211250000.00
GMED income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 71126000.00
GMED cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: 0.00
GMED cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -40000000.00
GMED income_statement (quarterly, 2025-09-30) — Research And Development: 38067000.00
GMED income_statement (quarterly, 2025-09-30) — Restructuring And Mergern Acquisition: -6155000.00
GMED balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 1292485000.00
GMED cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 0.00
GMED income_statement (quarterly, 2025-09-30) — Selling General And Administration: 313597000.00
GMED balance_sheet (quarterly, 2025-09-30) — Share Issued: 134605452.00
GMED cash_flow (quarterly, 2025-09-30) — Short Term Debt Payments: 0.00
GMED income_statement (quarterly, 2025-09-30) — Special Income Charges: 6155000.00
GMED cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 11538000.00
GMED balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 4398825000.00
GMED balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 2190632000.00
GMED income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 1042956.00
GMED income_statement (quarterly, 2025-09-30) — Tax Provision: 25028000.00
GMED income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.17
GMED balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 69007000.00
GMED balance_sheet (quarterly, 2025-09-30) — Total Assets: 5095640000.00
GMED balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 4398825000.00
GMED balance_sheet (quarterly, 2025-09-30) — Total Debt: 119343000.00
GMED balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 4398825000.00
GMED income_statement (quarterly, 2025-09-30) — Total Expenses: 634040000.00
GMED balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 696815000.00
GMED balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 3171279000.00
GMED balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 230857000.00
GMED income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 137363000.00
GMED income_statement (quarterly, 2025-09-30) — Total Other Finance Cost: -1455000.00
GMED balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 49324000.00
GMED income_statement (quarterly, 2025-09-30) — Total Unusual Items: 5994000.00
GMED income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 5994000.00
GMED balance_sheet (quarterly, 2025-09-30) — Work In Process: 63678000.00
GMED balance_sheet (quarterly, 2025-09-30) — Working Capital: 1458403000.00
GMED income_statement (annual, 2025-12-31) — +Operating Expense: 1443938000.00
GMED income_statement (quarterly, 2025-12-31) — +Operating Expense: 384003000.00
GMED income_statement (annual, 2025-12-31) — +Total Revenue: 2938931000.00
GMED income_statement (quarterly, 2025-12-31) — +Total Revenue: 826420000.00
GMED balance_sheet (annual, 2025-12-31) — Accounts Payable: 98852000.00
GMED balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 98852000.00
GMED balance_sheet (annual, 2025-12-31) — Accounts Receivable: 678938000.00
GMED balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 678938000.00
GMED balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -705000000.00
GMED balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -705000000.00
GMED balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 3169812000.00
GMED balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 3169812000.00
GMED balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -33434000.00
GMED balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -33434000.00
GMED income_statement (annual, 2025-12-31) — Amortization: 118194000.00
GMED income_statement (quarterly, 2025-12-31) — Amortization: 29360000.00
GMED income_statement (annual, 2025-12-31) — Amortization Of Intangibles Income Statement: 118194000.00
GMED income_statement (quarterly, 2025-12-31) — Amortization Of Intangibles Income Statement: 29360000.00
GMED balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 34964000.00
GMED balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 34964000.00
GMED income_statement (annual, 2025-12-31) — Basic Average Shares: 135215000.00
GMED income_statement (quarterly, 2025-12-31) — Basic Average Shares: 134411000.00
GMED income_statement (annual, 2025-12-31) — Basic EPS: 3.98
GMED income_statement (quarterly, 2025-12-31) — Basic EPS: 1.05
GMED cash_flow (annual, 2025-12-31) — Beginning Cash Position: 784438000.00
GMED cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 371769000.00
GMED balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 127573000.00
GMED balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 127573000.00
GMED cash_flow (annual, 2025-12-31) — Capital Expenditure: -174425000.00
GMED cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -46277000.00
GMED balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 118656000.00
GMED balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 118656000.00
GMED balance_sheet (annual, 2025-12-31) — Capital Stock: 135000.00
GMED balance_sheet (quarterly, 2025-12-31) — Capital Stock: 135000.00
GMED balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 526156000.00
GMED balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 526156000.00
GMED balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 557243000.00
GMED balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 557243000.00
GMED cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -679160000.00
GMED cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 13215000.00
GMED cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -355014000.00
GMED cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -111449000.00
GMED cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 753447000.00
GMED cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 248587000.00
GMED cash_flow (annual, 2025-12-31) — Change In Account Payable: 8487000.00
GMED cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 9141000.00
GMED cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 34217000.00
GMED cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 8775000.00
GMED cash_flow (annual, 2025-12-31) — Change In Inventory: -17598000.00
GMED cash_flow (quarterly, 2025-12-31) — Change In Inventory: -178000.00
GMED cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -50851000.00
GMED cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: 7085000.00
GMED cash_flow (annual, 2025-12-31) — Change In Payable: 8487000.00
GMED cash_flow (quarterly, 2025-12-31) — Change In Payable: 9141000.00
GMED cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 42704000.00
GMED cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 17916000.00
GMED cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 11132000.00
GMED cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 17821000.00
GMED cash_flow (annual, 2025-12-31) — Change In Receivables: -52182000.00
GMED cash_flow (quarterly, 2025-12-31) — Change In Receivables: -64153000.00
GMED cash_flow (annual, 2025-12-31) — Change In Working Capital: -66795000.00
GMED cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -21509000.00
GMED cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -52182000.00
GMED cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -64153000.00
GMED cash_flow (annual, 2025-12-31) — Changes In Cash: -280727000.00
GMED cash_flow (quarterly, 2025-12-31) — Changes In Cash: 150353000.00